亞太藥業(002370.SZ):控股股東及其一致行動人所持2700萬股將被司法變賣
格隆匯 2 月 22日丨亞太藥業(002370.SZ)公佈,公司近日通過淘寶網司法拍賣網絡平台查詢獲悉,公司控股股東浙江亞太集團有限公司(“亞太集團”)及其子公司紹興柯橋亞太房地產有限公司(“亞太房地產”)、陳堯根、鍾婉珍因與中國民生銀行股份有限公司紹興分行金融借款合同糾紛一案,浙江省紹興市越城區人民法院將於2021年3月7日10時起至2021年5月5日10時止(競價週期與延時除外)在浙江省紹興市越城區人民法院淘寶網司法拍賣網絡平台上(法院賬户名:浙江省紹興市越城區人民法院,法院主頁網址:https://sf.taobao.com/0575/03)對亞太集團持有的亞太藥業1100萬股股票、亞太房地產持有的亞太藥業1600萬股股票進行公開變賣,變賣期為60天。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.